A PROSPECTIVE STUDY ON THE EFFICACY OF METFORMIN IN OBESE AND NON-OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME


Saveetha Veerarajan, I Somasundaram, P Shanmugasundaram

Abstract


ABSTRACT
Objective: The aim of the study was to assess the efficacy of metformin on fasting blood glucose (FBG), postprandial blood glucose (PPBG), total
cholesterol (T. chol), blood pressure (BP), weight and hence body mass index (BMI) in women with polycystic ovary syndrome (PCOS).
Methods: In a prospective study, 90 women aged 18-45 were treated with metformin 500 mg twice daily for 1 year. women were grouped as obese
and non-obese based on their BMI. The changes in measured parameters were analyzed statistically.
Results: There was a reduction in weight, systolic BP (SBP), FBG, PPBG and T. chol (p=0.04, p=0.03, p=0.032, p=0.037, p=0.042 and p=0.047,
respectively) in the obese group. There was no significant difference in diastolic BP in both the groups.
Conclusion: Metformin treatment lowered weight and SBP and T. chol in women with PCOS. FBG and PPBG were also reduced in obese patients while
Non-obese women did not benefit from metformin.
Keywords: Polycystic ovary syndrome, Metformin, Obese, Non-obese.


| PDF | PDF |


About this article

Title

A PROSPECTIVE STUDY ON THE EFFICACY OF METFORMIN IN OBESE AND NON-OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Date

01-08-2016

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 9 Suppl 1 August 2016 Page: 145-147

Print ISSN

0974-2441

Online ISSN

2455-3891

Statistics

69 Views | 88 Downloads

Authors & Affiliations

Saveetha Veerarajan
India

I Somasundaram

P Shanmugasundaram


Article Tools


Email this article (Login required)
Email the author (Login required)

Refbacks

  • There are currently no refbacks.